T3	control 52 70	standard follow-up
T4	condition 107 122	breast fibrosis
T5	total-participants 386 397	Fifty-three
T6	eligibility 398 443	breast cancer patients with localized disease
T7	intervention-participants 585 587	26
T8	control-participants 615 617	27
T16	iv-bin-percent 1335 1339	100%
T17	cv-bin-percent 1349 1354	90.6%
T18	outcome 1380 1401	disease-free survival
T19	iv-bin-percent 1403 1408	96.2%
T20	cv-bin-percent 1418 1423	86.8%
T15	outcome 1317 1333	Overall survival
T1	intervention 20 48	pentoxifylline and vitamin E
T2	outcome 1714 1739	local control or survival
T10	outcome 1635 1661	radiation-induced fibrosis
T21	iv-cont-median 1193 1200	1.00 mm
T22	cv-cont-median 1234 1240	2.4 mm
T23	outcome 1797 1801	safe
T24	outcome 1806 1820	well tolerated
T14	outcome 1137 1153	TCM measurements
